MELD Exceptions and Rates of Waiting List Outcomes
Top Cited Papers
Open Access
- 15 September 2011
- journal article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 11 (11), 2362-2371
- https://doi.org/10.1111/j.1600-6143.2011.03735.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Hepatocellular Carcinoma Patients Are Advantaged in the Current Liver Transplant Allocation SystemAmerican Journal of Transplantation, 2010
- Liver Transplantation in the United States, 1999-2008American Journal of Transplantation, 2010
- Model for End Stage Liver Disease and hepatocellular carcinoma: a moving targetTransplantation Reviews, 2010
- OPTN Policy Regarding Prioritization of Patients with Hepatopulmonary Syndrome: Does It Provide Equitable Organ Allocation?American Journal of Transplantation, 2008
- Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formulaLiver Transplantation, 2006
- Model for end-stage liver disease (MELD) exception guidelinesLiver Transplantation, 2006
- Regional Variations in Peer Reviewed Liver Allocation Under the MELD SystemAmerican Journal of Transplantation, 2005
- New national liver transplant allocation policy: Is the regional review board process fair?Liver Transplantation, 2004
- Improving liver allocation: MELD and PELDAmerican Journal of Transplantation, 2004
- A model to predict survival in patients with end-stage liver diseaseHepatology, 2001